Literature DB >> 19038400

Associated symptoms in the ten days before diagnosis of Kawasaki disease.

Annette L Baker1, Minmin Lu, L LuAnn Minich, Andrew M Atz, Gloria L Klein, Rosalind Korsin, Linda Lambert, Jennifer S Li, Wilbert Mason, Elizabeth Radojewski, Victoria L Vetter, Jane W Newburger.   

Abstract

OBJECTIVE: To describe common associated symptoms within the 10 days before diagnosis in subjects enrolled in the Pediatric Heart Network's trial of steroid therapy in Kawasaki disease (KD). STUDY
DESIGN: Patients with acute KD were enrolled between days 4 and 10 of illness at 8 centers between 2002 and 2004. We defined common associated symptoms as those occurring in >or=10% of patients. Principal clinical criteria for KD were not included in this analysis.
RESULTS: Among 198 patients, irritability was reported in 98 (50%), vomiting in 88 (44%), decreased food/fluid intake in 73 (37%), cough in 55 (28%), diarrhea in 52 (26%), rhinorrhea in 37 (19%), weakness in 37 (19%), abdominal pain in 35 (18%), and joint pain (arthralgia or arthritis) in 29 (15%). One or more gastrointestinal symptom (vomiting, diarrhea, or abdominal pain) was present in 120 patients (61%) and 69 patients (35%) had >or= 1 respiratory symptom (rhinorrhea or cough).
CONCLUSIONS: Nonspecific symptoms occur commonly in children with KD. To reduce delays in diagnosis, clinicians should be educated that such symptoms may comprise a significant component in the chief complaint.

Entities:  

Mesh:

Year:  2008        PMID: 19038400      PMCID: PMC2745188          DOI: 10.1016/j.jpeds.2008.10.006

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

Review 1.  Kawasaki syndrome: clinical features. Pathophysiology, etiology and therapy.

Authors:  M E Melish; R V Hicks
Journal:  J Rheumatol Suppl       Date:  1990-09

2.  Infections and Kawasaki disease: implications for coronary artery outcome.

Authors:  Susanne M Benseler; Brian W McCrindle; Earl D Silverman; Pascal N Tyrrell; Joseph Wong; Rae S M Yeung
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

3.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

4.  Clinical and epidemiologic characteristics of patients referred for evaluation of possible Kawasaki disease. United States Multicenter Kawasaki Disease Study Group.

Authors:  J C Burns; W H Mason; M P Glode; S T Shulman; M E Melish; C Meissner; J Bastian; A S Beiser; H M Meyerson; J W Newburger
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406

5.  Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association.

Authors:  Jane W Newburger; Masato Takahashi; Michael A Gerber; Michael H Gewitz; Lloyd Y Tani; Jane C Burns; Stanford T Shulman; Ann F Bolger; Patricia Ferrieri; Robert S Baltimore; Walter R Wilson; Larry M Baddour; Matthew E Levison; Thomas J Pallasch; Donald A Falace; Kathryn A Taubert
Journal:  Circulation       Date:  2004-10-26       Impact factor: 29.690

6.  Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease.

Authors:  Jane W Newburger; Lynn A Sleeper; Brian W McCrindle; L LuAnn Minich; Welton Gersony; Victoria L Vetter; Andrew M Atz; Jennifer S Li; Masato Takahashi; Annette L Baker; Steven D Colan; Paul D Mitchell; Gloria L Klein; Robert P Sundel
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

7.  Prevalence of coronary artery abnormalities in Kawasaki disease is highly dependent on gamma globulin dose but independent of salicylate dose.

Authors:  M Terai; S T Shulman
Journal:  J Pediatr       Date:  1997-12       Impact factor: 4.406

Review 8.  Kawasaki syndrome.

Authors:  R V Hicks; M E Melish
Journal:  Pediatr Clin North Am       Date:  1986-10       Impact factor: 3.278

9.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients.

Authors:  H Kato; T Sugimura; T Akagi; N Sato; K Hashino; Y Maeno; T Kazue; G Eto; R Yamakawa
Journal:  Circulation       Date:  1996-09-15       Impact factor: 29.690

10.  Delayed diagnosis of Kawasaki disease: what are the risk factors?

Authors:  L LuAnn Minich; Lynn A Sleeper; Andrew M Atz; Brian W McCrindle; Minmin Lu; Steven D Colan; Beth F Printz; Gloria L Klein; Robert P Sundel; Masato Takahashi; Jennifer S Li; Victoria L Vetter; Jane W Newburger
Journal:  Pediatrics       Date:  2007-11-19       Impact factor: 7.124

View more
  29 in total

Review 1.  Gastrointestinal aspects of vasculitides.

Authors:  Medha Soowamber; Adam V Weizman; Christian Pagnoux
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-11-23       Impact factor: 46.802

2.  Concomitant respiratory viral infections in children with Kawasaki disease.

Authors:  Alejandro Jordan-Villegas; Michael L Chang; Octavio Ramilo; Asunción Mejías
Journal:  Pediatr Infect Dis J       Date:  2010-08       Impact factor: 2.129

3.  Immunoglobulin Resistance in Kawasaki Disease.

Authors:  Georgios A Hartas; Syed Shahrukh Hashmi; Chi Pham-Peyton; Emmanouil Tsounias; John T Bricker; Monesha Gupta-Malhotra
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2015-03-01       Impact factor: 1.349

4.  Kawasaki disease resembling acute colitis.

Authors:  Masazumi Miyahara; Masahiro Hirayama
Journal:  BMJ Case Rep       Date:  2013-01-03

5.  Appendicitis as the presenting manifestation of Kawasaki disease.

Authors:  Gwendolyn M Garnett; Sarah Kimball; Marian E Melish; Karen S Thompson; Devin P Puapong; Sidney M Johnson; Russell K Woo
Journal:  Pediatr Surg Int       Date:  2013-12-07       Impact factor: 1.827

6.  Infliximab treatment of pancreatitis complicating acute kawasaki disease.

Authors:  Susan G Jimenez-Fernandez; Adriana H Tremoulet
Journal:  Pediatr Infect Dis J       Date:  2012-10       Impact factor: 2.129

7.  Prevalence and characteristics of arthritis in Kawasaki disease: a Chinese cohort study.

Authors:  Yu Peng; Xiaohui Liu; Zhao Duan; Yuhong Deng; Sufen Cai; Zhi Wang; Kun Xu; Hui Kang; Man Jiang; Lin Li; Yulan Zhou; Zheng Zou
Journal:  Clin Exp Med       Date:  2019-02-06       Impact factor: 3.984

8.  Atypical Kawasaki syndrome in COVID-19 infection: a case report of a multisystem inflammatory syndrome in a child (MIS-C).

Authors:  Justice Sylverken; Priscilla Afari; Charles Martyn-Dickens; Sheila A Owusu; Emmanuel Oppong; Francis Akwetey; Ekow Mensah; Haruna Mahama; Sandra K Owusu; Sampson Antwi
Journal:  Ghana Med J       Date:  2021-06

9.  Associated symptoms of kawasaki disease.

Authors:  Sang Hyun Yun; Nu Ri Yang; Sin Ae Park
Journal:  Korean Circ J       Date:  2011-07-30       Impact factor: 3.243

10.  Urine proteomics for discovery of improved diagnostic markers of Kawasaki disease.

Authors:  Alex Kentsis; Andrew Shulman; Saima Ahmed; Eileen Brennan; Michael C Monuteaux; Young-Ho Lee; Susan Lipsett; Joao A Paulo; Fatma Dedeoglu; Robert Fuhlbrigge; Richard Bachur; Gary Bradwin; Moshe Arditi; Robert P Sundel; Jane W Newburger; Hanno Steen; Susan Kim
Journal:  EMBO Mol Med       Date:  2012-12-20       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.